{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:53:46Z","timestamp":1783745626767,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["onlinejcf.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cardfail.2023.08.025","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T15:21:27Z","timestamp":1697901687000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel Nebulized Milrinone Formulation for the Treatment of Acute Heart Failure Requiring Inotropic Therapy: A Phase 1 Study"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-0146","authenticated-orcid":false,"given":"ZACHARY L.","family":"COX","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TARUN","family":"DALIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMANDEEP","family":"GOYAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN","family":"FRITZLEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BHANU","family":"GUPTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZUBAIR","family":"SHAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREW J.","family":"SAUER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NICHOLAS A.","family":"HAGLUND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2023.08.025_bib0001","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0002","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0003","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cardfail.2014.06.004","article-title":"Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone?","volume":"20","author":"Haglund","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0004","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjcard.2015.12.030","article-title":"Infections, arrhythmias, and hospitalizations on home intravenous inotropic therapy","volume":"117","author":"Acharya","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0005","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0006","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/ejhf.1557","article-title":"Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials","volume":"21","author":"Ahmad","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0007","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1074248413489773","article-title":"Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction","volume":"18","author":"Cox","year":"2013","journal-title":"J Cardiovasc Pharmacol Therapeut"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0008","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.amjcard.2018.06.009","article-title":"Extended-release oral milrinone, CRD-102, for advanced heart failure","volume":"122","author":"Nanayakkara","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0009","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cardfail.2015.04.011","article-title":"Inhaled milrinone after left ventricular assist device implantation","volume":"21","author":"Haglund","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0010","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12630-016-0709-8","article-title":"A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients","volume":"63","author":"Denault","year":"2016","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0011","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/00000539-200112000-00018","article-title":"The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension","volume":"93","author":"Haraldsson s","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0012","series-title":"Milrinone lactate injection package labeling","year":"2011"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0013","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0735-1097(87)80223-1","article-title":"Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study","volume":"9","author":"Anderson","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0014","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI111742","article-title":"Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: dose-response relationships and comparison to nitroprusside","volume":"75","author":"Jaski","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0002-9149(85)91036-7","article-title":"Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure","volume":"56","author":"Benotti","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0016","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000542-199409000-00014","article-title":"Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery","volume":"81","author":"Bailey","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0017","first-page":"16","article-title":"The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass","volume":"85","author":"Kikura","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0018","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cardfail.2021.06.015","article-title":"Use of outpatient intravenous calcitropes for heart failure in the United States","volume":"27","author":"Gottlieb","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0019","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","article-title":"Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure","volume":"2","author":"Gorodeski","year":"2009","journal-title":"Circulation Heart Fail"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCULATIONAHA.117.028747","article-title":"An unintended consequence of the 21st-century cures act for patients with heart failure","volume":"136","author":"Gilstrap","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0021","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJM199812173392503","article-title":"A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure","volume":"339","author":"Cohn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0022","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.115.002481","article-title":"Chronic inotropic therapy in the Current era: old wines with new pairings","volume":"8","author":"Pinney","year":"2015","journal-title":"Circulation Heart Fail"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0023","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015026","article-title":"Extended-release oral milrinone for the treatment of heart failure with preserved ejection fraction","volume":"9","author":"Nanayakkara","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2023.08.025_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007286","article-title":"Oral milrinone for the treatment of chronic severe right ventricular failure in left ventricular assist device patients","volume":"14","author":"Uriel","year":"2021","journal-title":"Circulation Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423003524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423003524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:10:38Z","timestamp":1718464238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423003524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1071916423003524"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.08.025","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Nebulized Milrinone Formulation for the Treatment of Acute Heart Failure Requiring Inotropic Therapy: A Phase 1 Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}